NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

K/M ALWAYS overshoots the actual already living that long until all data is in.

Not exactly sure what that statement means Ex.

But the 28.2% is almost a final figure. If it showed a confidence interval it would be no more than 1% either way. Only a handful of subjects who joined late Oct/Nov would not have their data included.
Perhaps 10 or less.
Given the indicators of ridiculously good survival for the 2015 intake, I would forecast that this 28.2% will not go down.
rather it is likely to go up a fraction of 1%.

Of course the bigger and more important question is what is the separation between treatment and control on OS36.